scholarly journals Psychospołeczne uwarunkowania oceny znaczenia własnej choroby przez osoby przewlekle chore

2018 ◽  
Vol 45 ◽  
pp. 245-262
Author(s):  
Joanna Furmańska Joanna Furmańska ◽  
Teresa Rzepa ◽  
Maria Pietrzak-Nowacka ◽  
Dorota Koziarska

The literature on the subject identifies chronic disease as a stressor which imposes new adaptive tasks on patients and requires them to change their lifestyle. Therefore, the issues of disease assessment and adaptation to illness, based on individual knowledge of the disease and subjective appraisal of its influence on day-to-day functioning, are becoming increasingly important. In the present article, the appraisal of disease significance is to be understood as a dynamic effect of subjective assessment of one’s own life situation due to chronic disease. The aim of the analysis was validation of the relationship between the basic sociodemographic factors and the appraisal of the significance of a chronic disease among patients with RRMS and diabetes type 2, as well as verification whether these two diseases show any differences in terms of appraisal of their significance in opinion of the patients. In order to verify the hypotheses, The Disease-Related Appraisals Scale, and original scorecard designed to obtain sociodemographic data were used. The analysis was conducted on 118 patients with RRMS and 61 patients with diabetes type 2. The results show a statistically significant relationship between education level and the appraisal of disease significance considered as benefit and injustice among the two groups of patients. Additionally, in the group of patients with diabetes type 2, the aforementioned relationship was also found for appraisal of disease significance considered as a threat. Moreover, it was found that the analysed groups show significant differences in terms of recognition of the disease as an obstacle/loss. Diagnostic assessment of disease significance sets the direction and methods of therapeutic intervention provided, with the primary aim of improving the quality of life of patients suffering from a chronic disease.

2020 ◽  
Vol 2 (1) ◽  
pp. 12-16
Author(s):  
Fennoun H ◽  
Haraj NE ◽  
El Aziz S ◽  
Bensbaa S ◽  
Chadli A

Introduction: Hyperuricemia is common Type 2 diabetes at very high cardiovascular risk. Objective: Evaluate the relationship between hyperuricemia and diabetes type 2, and determine its predictive factors in this population. Patients and Methods: Retrospective study cross including 190 patients with diabetes type 2 hospitalized Service of Endocrinology of CHU Ibn Rushd Casablanca from January 2015 to December 2017. Hyperuricemia was defined as a serum uric acid concentration> 70 mg/L (men) and> 60 mg/L (women). The variables studied were the anthropometric measurements), cardiovascular factors (tobacco, hypertension, dyslipidemia), and degenerative complications (retinopathy, neuropathy, kidney failure, ischemic heart disease). The analyzes were performed by SPSS software. Results: Hyperuricemia was found in 26.5% of patients with a female predominance (76%), an average age of 55.9 years, and an average age of 12.4ans diabetes. The glycemic control was found in 84.6% of cases with mean glycated hemoglobin 8.6%. Factors associated al hyperuricemia were the blood pressure in 86% (p <0.05), dyslipidemia in 76.3% of cases (p <0.001) with hypertriglyceridemia in 48.3% of cases (p <0.02), and a hypoHDLémie 28% (p <0.001). The age, obesity, smoking, and glycemic control were associated significantly n al hyperuricemia. The research of degenerative complications of hyperuricemia has objectified renal impairment (GFR between 15 and 60ml / min) chez47% (p <0.001), it was kind of moderate in 35.8% (p <0.01) and severe in 5.1% (p <0.02), ischemic heart disease was found in 34% of cases (p <0.01). Conclusion: In our study, hyperuricemia in type 2 diabetes is common in female patients, especially with hypertension, dyslipidemia, and renal failure. Other factors such as age, obesity, smoking is not associated with hyperuricemia in type 2 diabetics.


2006 ◽  
Vol 6 (2) ◽  
pp. 54-58
Author(s):  
Belma Aščić - Buturović

Combination of insulin and metformin has been shown to improve glycaemic control in clinical trials, particularly in obese patients with diabetes type 2. Insulin therapy can improve function of pancreatic beta cells and periphery insulin activity in target cells in order to enhance glycaemic homeostasis (1, 2, 3). In our study we included obese patients with diabetes type 2 in the early stage of the disease. The study is partially retrospective and partially prospective. The study encompassed 40 patients split in two groups. The first group of 20 patients received insulin therapy combined with metformin, while the patients of the second group were treated with oral antidiabetic drugs, sulfonylureas and metformin. Three months later, the group treated with insulin and metformin showed improvement in the monitored parameters, namely significant reduction in HbA1c (p = 0.003), MFBG (p = 0.0009), PPG (p = 0.028). Insulin therapy administered together with metformin, in obese patients with diabetes type 2, in the early stage of the disease, resulted in well regulated fasting blood glycaemia, as well as post challenge glycaemia and HbA1c.


2019 ◽  
Vol 152 (11) ◽  
pp. 438-441
Author(s):  
Pedro Pujante ◽  
Jessica Ares ◽  
Carmen Maciá ◽  
Raúl Rodriguez Escobedo ◽  
Edelmiro Menéndez ◽  
...  

CHEST Journal ◽  
2006 ◽  
Vol 130 (4) ◽  
pp. 172S
Author(s):  
Alexander E. Makarevich ◽  
Valentina E. Valevich ◽  
Alexander J. Pochtavcev

2007 ◽  
Vol 46 (6) ◽  
pp. 1111-1118 ◽  
Author(s):  
Peter Rosenberg ◽  
Hanna Urwitz ◽  
Anders Johannesson ◽  
Anne-Marie Ros ◽  
Johan Lindholm ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document